{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:37Z","timestamp":1772165617994,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670497"],"award-info":[{"award-number":["81670497"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701746"],"award-info":[{"award-number":["81701746"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clinicians aim to prevent progression of Crohn\u2019s disease (CD); however, many patients require surgical resection because of cumulative bowel damage. The aim of this study was to evaluate the impact of early intervention on bowel damage in patients with CD using the L\u00e9mann Index and to identify bowel resection predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed consecutive patients with CD retrospectively. The L\u00e9mann Index was determined at the point of inclusion and at follow-up termination. The Paris definition was used to subdivide patients into early and late CD groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 154 patients, comprising 70 with early CD and 84 with late CD. After follow-up for 17.0\u00a0months, more patients experienced a decrease in the L\u00e9mann Index (61.4% vs. 42.9%), and fewer patients showed an increase in the L\u00e9mann Index (20% vs. 35.7%) in the early compared with the late CD group. Infliximab and other therapies reversed bowel damage to a greater extent in early CD patients than in late CD patients. Twenty-two patients underwent intestinal surgery, involving 5 patients in the early CD group and 17 patients in the late CD group. Three independent predictors of bowel resection were identified: baseline L\u00e9mann index\u2009\u2265\u20098.99, disease behavior B1, and history of intestinal surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early intervention within 18\u00a0months after CD diagnosis could reverse bowel damage and decrease short-term intestinal resection. Patients with CD with a history of intestinal surgery, and\/or a L\u00e9mann index\u2009&gt;\u20098.99 should be treated aggressively and monitored carefully to prevent progressive bowel damage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-020-01575-7","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T08:04:58Z","timestamp":1607673898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of early intervention on the bowel damage and intestinal surgery of Crohn\u2019s disease, based on the L\u00e9mann index"],"prefix":"10.1186","volume":"20","author":[{"given":"Mingming","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xitao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunqi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"1575_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46\u201354.","journal-title":"Gastroenterology"},{"key":"1575_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa029","author":"S Jangi","year":"2020","unstructured":"Jangi S, Ruan A, Korzenik J, et al. South Asian patients with inflammatory bowel disease in the united states demonstrate more fistulizing and perianal crohn phenotype. Inflamm Bowel Dis. 2020. https:\/\/doi.org\/10.1093\/ibd\/izaa029.","journal-title":"Inflamm Bowel Dis"},{"key":"1575_CR3","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/ecco-jcc\/jjz081","volume":"13","author":"SH Park","year":"2019","unstructured":"Park SH, Kim YJ, Rhee KH, et al. A 30-year trend analysis in the epidemiology of inflammatory bowel disease in the Songpa-Kangdong District of Seoul, Korea in 1986\u20132015. J Crohns Colitis. 2019;13:1410\u20137.","journal-title":"J Crohns Colitis"},{"key":"1575_CR4","first-page":"1839","volume":"19","author":"J Zhao","year":"2013","unstructured":"Zhao J, Ng SC, Lei Y, et al. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of \u201cwestern\u201d disease. Inflamm Bowel Dis. 2013;19:1839\u201345.","journal-title":"Inflamm Bowel Dis"},{"key":"1575_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/jgh.12164","volume":"28","author":"Z Zeng","year":"2013","unstructured":"Zeng Z, Zhu Z, Yang Y, et al. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study. J Gastroenterol Hepatol. 2013;28:1148\u201353.","journal-title":"J Gastroenterol Hepatol"},{"key":"1575_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ajg.2009.579","volume":"105","author":"L Peyrin-Biroulet","year":"2010","unstructured":"Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, et al. The natural history of adult Crohn\u2019s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289\u201397.","journal-title":"Am J Gastroenterol"},{"key":"1575_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","volume":"6","author":"G Roda","year":"2020","unstructured":"Roda G, Chien Ng S, Kotze PG, et al. Crohn\u2019s disease. Nat Rev Dis Primers. 2020;6:22.","journal-title":"Nat Rev Dis Primers"},{"key":"1575_CR8","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/ecco-jcc\/jjz065","volume":"13","author":"A Schoepfer","year":"2019","unstructured":"Schoepfer A, Santos J, Fournier N, et al. Systematic analysis of the impact of diagnostic delay on bowel damage in paediatric versus adult onset crohn\u2019s disease. J Crohns Colitis. 2019;13:1334\u201342.","journal-title":"J Crohns Colitis"},{"key":"1575_CR9","doi-asserted-by":"crossref","unstructured":"Fiorino G, Bonifacio C, Peyrin-Biroulet L, Danese S. Preventing collateral damage in Crohn\u2019s disease: the L\u00e9mann index. J Crohn's Colitis 2016; 10(4), 495-500","DOI":"10.1093\/ecco-jcc\/jjv240"},{"key":"1575_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2014.09.015","volume":"148","author":"B Pariente","year":"2015","unstructured":"Pariente B, Mary JY, Danese S, et al. Development of the Lemann index to assess digestive tract damage in patients with Crohn\u2019s disease. Gastroenterology. 2015;148:52\u201363.","journal-title":"Gastroenterology"},{"key":"1575_CR11","doi-asserted-by":"crossref","unstructured":"Lauriot Dit Prevost C, Azahaf M, Nachury M, et al. Bowel damage and disability in Crohn's disease: a prospective study in a tertiary referral centre of the Lemann Index and Inflammatory Bowel Disease Disability Index. Aliment Pharmacol Ther. 2020; 51: 889\u2013898.","DOI":"10.1111\/apt.15681"},{"key":"1575_CR12","doi-asserted-by":"crossref","unstructured":"Bodini G, Giannini EG, De Maria C, et al. Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lemann Index. Dig Liver Dis. 2017; 49: 175\u2013180.","DOI":"10.1016\/j.dld.2016.10.014"},{"key":"1575_CR13","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1007\/s10620-018-5434-4","volume":"64","author":"H Panchal","year":"2019","unstructured":"Panchal H, Wagner M, Chatterji M, et al. Earlier anti-tumor necrosis factor therapy of Crohn\u2019s disease correlates with slower progression of bowel damage. Dig Dis Sci. 2019;64:3274\u201383.","journal-title":"Dig Dis Sci"},{"key":"1575_CR14","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/ajg.2012.117","volume":"107","author":"L Peyrin-Biroulet","year":"2012","unstructured":"Peyrin-Biroulet L, Billioud V, D\u2019Haens G, et al. Development of the Paris definition of early Crohn\u2019s disease for disease-modification trials: results of an international expert opinion process. Am J Gastroenterol. 2012;107:1770\u20136.","journal-title":"Am J Gastroenterol"},{"key":"1575_CR15","doi-asserted-by":"publisher","first-page":"e11814","DOI":"10.1097\/MD.0000000000011814","volume":"97","author":"X Qian","year":"2018","unstructured":"Qian X, Wang T, Shen J, et al. Low dose of azathioprine is effective to induce and maintain remission in active Crohn disease: A prospective observational study. Medicine (Baltimore). 2018;97:e11814.","journal-title":"Medicine (Baltimore)"},{"key":"1575_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/MIB.0000000000000980","volume":"23","author":"A Rispo","year":"2017","unstructured":"Rispo A, Imperatore N, Testa A, et al. Bowel damage in crohn\u2019s disease: direct comparison of ultrasonography-based and magnetic resonance-based Lemann index. Inflamm Bowel Dis. 2017;23:143\u201351.","journal-title":"Inflamm Bowel Dis"},{"key":"1575_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/apt.13363","volume":"42","author":"E Safroneeva","year":"2015","unstructured":"Safroneeva E, Vavricka SR, Fournier N, et al. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn\u2019s disease. Aliment Pharmacol Ther. 2015;42:977\u201389.","journal-title":"Aliment Pharmacol Ther"},{"key":"1575_CR18","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/ecco-jcc\/jjv130","volume":"9","author":"V Nuij","year":"2015","unstructured":"Nuij V, Fuhler GM, Edel AJ, et al. Benefit of earlier Anti-TNF treatment on IBD disease complications? J Crohns Colitis. 2015;9:997\u20131003.","journal-title":"J Crohns Colitis"},{"key":"1575_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/jgh.13169","volume":"31","author":"B Kim","year":"2016","unstructured":"Kim B, Cheon JH, Moon HJ, et al. Crohn\u2019s disease prognosis and early immunomodulator therapy: results from the CONNECT study. J Gastroenterol Hepatol. 2016;31:126\u201332.","journal-title":"J Gastroenterol Hepatol"},{"key":"1575_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-230X-14-85","volume":"14","author":"MS Kwak","year":"2014","unstructured":"Kwak MS, Kim DH, Park SJ, et al. Efficacy of early immunomodulator therapy on the outcomes of Crohn\u2019s disease. BMC Gastroenterol. 2014;14:85.","journal-title":"BMC Gastroenterol"},{"key":"1575_CR21","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1136\/gutjnl-2017-314519","volume":"66","author":"S Danese","year":"2017","unstructured":"Danese S, Fiorino G, Peyrin-Biroulet L. Early intervention in Crohn\u2019s disease: towards disease modification trials. Gut. 2017;66:2179\u201387.","journal-title":"Gut"},{"key":"1575_CR22","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/apt.14030","volume":"45","author":"A Cholapranee","year":"2017","unstructured":"Cholapranee A, Hazlewood GS, Kaplan GG, et al. Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn\u2019s disease and ulcerative colitis controlled trials. Aliment Pharmacol Ther. 2017;45:1291\u2013302.","journal-title":"Aliment Pharmacol Ther"},{"key":"1575_CR23","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/MCG.0000000000000441","volume":"50","author":"EL Barnes","year":"2016","unstructured":"Barnes EL, Allegretti JR. Are anti-tumor necrosis factor trough levels predictive of mucosal healing in patients with inflammatory bowel disease? A systematic review and meta-analysis. J Clin Gastroenterol. 2016;50:733\u201341.","journal-title":"J Clin Gastroenterol"},{"key":"1575_CR24","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/j.1572-0241.2006.00552.x","volume":"101","author":"I Vind","year":"2006","unstructured":"Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003\u20132005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101:1274\u201382.","journal-title":"Am J Gastroenterol"},{"key":"1575_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/jgh.14000","volume":"33","author":"Y Qiu","year":"2018","unstructured":"Qiu Y, Chen BL, Feng R, et al. Prolonged azathioprine treatment reduces the need for surgery in early Crohn\u2019s disease. J Gastroenterol Hepatol. 2018;33:664\u201370.","journal-title":"J Gastroenterol Hepatol"},{"key":"1575_CR26","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1097\/MIB.0000000000000846","volume":"22","author":"SC Ng","year":"2016","unstructured":"Ng SC, Leung WK, Shi HY, et al. Epidemiology of inflammatory bowel disease from 1981 to 2014: results from a territory-wide population-based registry in Hong Kong. Inflamm Bowel Dis. 2016;22:1954\u201360.","journal-title":"Inflamm Bowel Dis"},{"key":"1575_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/DCR.0000000000000930","volume":"61","author":"W Liu","year":"2018","unstructured":"Liu W, Zhou W, Xiang J, et al. Lemann index at diagnosis predicts the risk of early surgery in Crohn\u2019s disease. Dis Colon Rectum. 2018;61:207\u201313.","journal-title":"Dis Colon Rectum"},{"key":"1575_CR28","doi-asserted-by":"publisher","unstructured":"Zhu M, Xu X, Feng Q, et al. Effectiveness of infliximab on deep radiological remission in chinese patients with perianal fistulizing Crohn's disease [published online ahead of print, 2020 Jun 10]. Dig Dis Sci. 2020. doi:https:\/\/doi.org\/10.1007\/s10620-020-06398-w","DOI":"10.1007\/s10620-020-06398-w"},{"key":"1575_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/gutjnl-2011-300049","volume":"61","author":"L Peyrin-Biroulet","year":"2012","unstructured":"Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut. 2012;61:241\u20137.","journal-title":"Gut"},{"key":"1575_CR30","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1007\/s10620-016-4189-z","volume":"61","author":"S Nahon","year":"2016","unstructured":"Nahon S, Lahmek P, Paupard T, Lesgourgues B, Chaussade S, Peyrin-Biroulet L, et al. Diagnostic delay is associated with a greater risk of early surgery in a French cohort of Crohn\u2019s disease patients. Dig Dis Sci. 2016;61:3278\u201384.","journal-title":"Dig Dis Sci"},{"key":"1575_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/ecco-jcc\/jjx002.512","volume":"11","author":"G Fiorino","year":"2017","unstructured":"Fiorino G, Morin M, Bonovas S, Bonifacio C, Spinelli A, Germain A, et al. Prevalence of bowel damage assessed by cross-sectional imaging in early crohn\u2019s disease and its impact on disease outcome. J Crohns Colitis. 2017;11:274\u201380.","journal-title":"J Crohns Colitis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01575-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-020-01575-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01575-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T08:08:55Z","timestamp":1607674135000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-01575-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1575"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-01575-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-73606\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"7 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Research Ethics Committee of Renji Hospital approved the present study. Individual consent was not necessary according to local ethical regulation in a retrospective investigation based on the hospital data management system as performed here.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}